Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: J Neuroimmune Pharmacol. 2012 Mar 28;7(4):856–865. doi: 10.1007/s11481-012-9351-6

Table 1. Cytotoxicity assessed by LDH assay.

Values represent means, expressed as a percentage of total LDH activity induced by 1% Triton X-100. Supernatants of vehicle- and ligand- treated GPR55E U2OS cells are similar to each other in that they demonstrate little to no cellular damage, 7% and 6–9% of LDH activity, respectively.

Treatment Cell death, %

HBSS 5.97
Vehicle 7.12
3μM LPI 7.08
30 μM SR141716A 7.12
10 μM Virodhamine 7.27
10 μM Virodhamine +3 μM LPI 6.94
10 μM Virodhamine + 30 μM SR141716A 6.44
30 μM Virodhamine 8.08
30 μM Virodhamine + 3μM LPI 8.73
30 μM Virodhamine +30 μM SR141716A 6.93
10 μM AEA 5.90
10 μM AEA+ 3μM LPI 6.12
10 μM AEA + 30 μM SR141716A 6.79
30 μM AEA 5.93
30 μM AEA + 3 μM LPI 5.86
30 μM AEA + 30 μM SR141716A 8.02